Herman H. Yue

Herman's representative experience includes representing:

• Jazz Pharmaceuticals v. Avadel: Avadel in a series of patent infringement lawsuits relating to Avadel’s novel LUMRYZ narcolepsy medication
• Bristol-Myers Squibb v. Nanocopoeia: Nanocopoeia in a patent infringement lawsuit relating to Nanocopoeia’s novel leukemia treatment
• AbbVie in multiple lawsuits under the BPCIA involving Humira®, the first humanized monoclonal antibody drug
• The developer and distributor of a branded pharmaceutical in an IP lawsuit against a multinational generic pharmaceutical company
• Icahn School of Medicine v. Neurocrine Biosciences: Neurocrine in a contract dispute involving patents covering recombinant DNA constructs
• Enzo Life Sciences v. Life Technologies: Life Technologies in patent litigation relating to DNA sequencing technology 
• Enerpol v. Schlumberger Technology Corp.: Schlumberger in patent litigation involving polymer-based fracking technology
• RLIS v. Cerner Corp.: Cerner, as trial counsel, in patent litigation over medical records software, in which the patents were found invalid and not infringed* 
• Tyco Healthcare Group v. Mutual: A client in obtaining summary judgment on antitrust claims arising out of Abbreviated New Drug Application (ANDA) litigation*
• A major pharmaceutical company, as trial counsel, in ANDA litigation over its blockbuster HIV protease inhibitor drug, in which the patents were found valid and infringed* 
• A major medical device manufacturer, as trial counsel, in patent litigation relating to its blockbuster drug-eluting cardiac stents*

*Matter handled prior to joining Latham